127 related articles for article (PubMed ID: 24936938)
1. Socioeconomic disparities in diagnostic testing after positive aneuploidy screening.
Wong AE; Dungan J; Feinglass J; Grobman WA
Am J Perinatol; 2015 Feb; 30(2):205-10. PubMed ID: 24936938
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
4. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
Lostchuck E; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
[TBL] [Abstract][Full Text] [Related]
5. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
6. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
[TBL] [Abstract][Full Text] [Related]
7. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings.
Meck JM; Kramer Dugan E; Matyakhina L; Aviram A; Trunca C; Pineda-Alvarez D; Aradhya S; Klein RT; Cherry AM
Am J Obstet Gynecol; 2015 Aug; 213(2):214.e1-5. PubMed ID: 25843063
[TBL] [Abstract][Full Text] [Related]
9. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
10. A new model for providing cell-free DNA and risk assessment for chromosome abnormalities in a public hospital setting.
Wallerstein R; Jelks A; Garabedian MJ
J Pregnancy; 2014; 2014():962720. PubMed ID: 25101177
[TBL] [Abstract][Full Text] [Related]
11. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
Hume H; Chasen ST
Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
[TBL] [Abstract][Full Text] [Related]
12. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
Chasen ST; McCullough LB; Chervenak FA
Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
[TBL] [Abstract][Full Text] [Related]
13. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Obstet Gynecol; 2014 Jun; 123(6):1303-1310. PubMed ID: 24807333
[TBL] [Abstract][Full Text] [Related]
14. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
15. Beyond the first trimester screen: can we predict who will choose invasive testing?
van Landingham S; Bienstock J; Wood Denne E; Hueppchen N
Genet Med; 2011 Jun; 13(6):539-44. PubMed ID: 21415760
[TBL] [Abstract][Full Text] [Related]
16. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital.
Yao H; Jiang F; Hu H; Gao Y; Zhu Z; Zhang H; Wang Y; Guo Y; Liu L; Yuan Y; Zhou L; Wang J; Du B; Qu N; Zhang R; Dong Y; Xu H; Chen F; Jiang H; Liu Y; Zhang L; Tian Z; Liu Q; Zhang C; Pan X; Yang S; Zhao L; Wang W; Liang Z
Ultrasound Obstet Gynecol; 2014 Jul; 44(1):17-24. PubMed ID: 24616044
[TBL] [Abstract][Full Text] [Related]
17. Patient acceptance of non-invasive testing for fetal aneuploidy via cell-free fetal DNA.
Vahanian SA; Baraa Allaf M; Yeh C; Chavez MR; Kinzler WL; Vintzileos AM
J Matern Fetal Neonatal Med; 2014 Jan; 27(1):106-9. PubMed ID: 23687914
[TBL] [Abstract][Full Text] [Related]
18. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA).
Dobson LJ; Reiff ES; Little SE; Wilkins-Haug L; Bromley B
Prenat Diagn; 2016 May; 36(5):456-62. PubMed ID: 26938930
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population.
Song Y; Liu C; Qi H; Zhang Y; Bian X; Liu J
Prenat Diagn; 2013 Jul; 33(7):700-6. PubMed ID: 23703459
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
